BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32359452)

  • 1. Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.
    Smith EML; Kuisell C; Kanzawa-Lee GA; Bridges CM; Alberti P; Cavaletti G; Saad R; Park S;
    Lancet Haematol; 2020 May; 7(5):e408-e417. PubMed ID: 32359452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers.
    Gilchrist LS; Tanner L
    Support Care Cancer; 2013 Mar; 21(3):847-56. PubMed ID: 22993026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
    Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
    JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity.
    Alberti P; Bernasconi DP; Cornblath DR; Merkies ISJ; Park SB; Velasco R; Bruna J; Psimaras D; Koeppen S; Pace A; Dorsey SG; Argyriou AA; Kalofonos HP; Briani C; Schenone A; Faber CG; Mazzeo A; Grisold W; Valsecchi M; Cavaletti G;
    Neurology; 2021 Aug; 97(7):e660-e672. PubMed ID: 34078718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
    Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.
    Gilchrist LS; Marais L; Tanner L
    Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties.
    Griffith KA; Merkies IS; Hill EE; Cornblath DR
    J Peripher Nerv Syst; 2010 Dec; 15(4):314-25. PubMed ID: 21199103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
    Smith EM; Beck SL; Cohen J
    Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity.
    Park SB; Alberti P; Kolb NA; Gewandter JS; Schenone A; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S13-S25. PubMed ID: 31647154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve excitability assessment in chemotherapy-induced neurotoxicity.
    Park SB; Lin CS; Kiernan MC
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22565594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
    Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
    Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
    Molassiotis A; Suen LKP; Cheng HL; Mok TSK; Lee SCY; Wang CH; Lee P; Leung H; Chan V; Lau TKH; Yeo W
    Integr Cancer Ther; 2019; 18():1534735419836501. PubMed ID: 30905173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.
    Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D
    Support Care Cancer; 2019 Dec; 27(12):4771-4777. PubMed ID: 30972648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
    Cavaletti G; Alberti P; Marmiroli P
    Am Soc Clin Oncol Educ Book; 2015; ():e553-60. PubMed ID: 25993222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.
    Haryani H; Fetzer SJ; Wu CL; Hsu YY
    Oncol Nurs Forum; 2017 May; 44(3):E111-E123. PubMed ID: 28635977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
    McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB;
    Support Care Cancer; 2017 Nov; 25(11):3485-3493. PubMed ID: 28589310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review.
    Smith EML; Kuisell C; Cho Y; Kanzawa-Lee GA; Gilchrist LS; Park SB; Scott MR; Alberti P;
    Cancer Treat Res Commun; 2021; 28():100420. PubMed ID: 34225104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy.
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Friedlander M; Bosco A; Harrison M; Maier N; O'Neill S; Park SB
    J Pain Symptom Manage; 2019 Dec; 58(6):1023-1032. PubMed ID: 31374367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.